UnitedHealth Exceeds Q1 2026 Earnings Forecasts and Raises Full-Year Profit Outlook
In its first-quarter results for 2026, UnitedHealth Group exceeded expectations, prompting an increase in its full-year profit forecast to adjusted earnings of over $18.25 per share, up from a previous estimate of above $17.75. The adjusted earnings for the quarter reached $7.23 per share, surpassing the consensus of $6.57. Total revenue rose to $111.72 billion from $109.58 billion the previous year. Net income stood at $6.28 billion, translating to $6.90 per share. The medical benefit ratio improved to 83.9%, better than the anticipated 85.5%. While Optum revenue fell to $24.1 billion, Optum Rx saw a 2% increase to $35.7 billion. CEO Stephen Hemsley emphasized ongoing healthcare modernization efforts, with full-year revenue guidance maintained at over $439 billion.
Key facts
- UnitedHealth beat Q1 2026 earnings expectations
- Raised full-year 2026 adjusted earnings guidance to over $18.25 per share
- Q1 adjusted earnings were $7.23 per share vs. $6.57 consensus
- Medical benefit ratio improved to 83.9% from 84.8% year-over-year
- Optum unit revenue declined slightly to $24.1 billion
- Stock rose almost 6% in premarket trading
- Full-year revenue guidance maintained at over $439 billion
- Projected loss of roughly 1.3 million Medicaid members
Entities
Institutions
- UnitedHealth Group
- LSEG
- Reuters
- CNBC
- Optum
- Optum Rx
Sources
- Quartz —